Retatrutide 15mg — Vial Spec, Reconstitution Math & COA
A 15mg vial of retatrutide supplies high-purity, lyophilized peptide designed for controlled in vitro and preclinical research applications. This technical guide outlines chemical specifications, concentration calculations across common diluent volumes, lot-matched analytical verification, and handling protocols for institutional laboratories.
Quick answer
A 15mg vial of retatrutide supplies high-purity, lyophilized peptide designed for controlled in vitro and preclinical research applications. This technical guide outlines chemical specifications, concentration calculations across common diluent volumes, lot-matched analytical verification, and handling protocols for institutional laboratories.
Key takeaways
- A 15mg [retatrutide](/research-peptides/retatrutide) research vial contains precisely measured, freeze-dried (lyophilized) peptide synthesized for advanced biochemical investigation.
- [Retatrutide](/research-peptides/retatrutide) operates as a unimolecular multi-agonist, engaging GIPR, GLP-1R, and GCGR to initiate downstream intracellular signaling cascades via heterotrimeric G-protein activation.
- When designing comparative metabolic experiments, researchers frequently benchmark [retatrutide](/research-peptides/retatrutide) against established single- and dual-acting incretin mimetics.
- Accurate reconstitution of a 15mg [retatrutide](/research-peptides/retatrutide) vial is critical for achieving target working concentrations in laboratory protocols.
Overview of Retatrutide 15mg Vial Specifications
A 15mg retatrutide research vial contains precisely measured, freeze-dried (lyophilized) peptide synthesized for advanced biochemical investigation. Retatrutide is a synthetic peptide engineered to interact with three distinct metabolic neuroendocrine receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon (GCG) receptor. In laboratory settings, the 15mg vial configuration is primary targeted toward researchers conducting multi-arm rodent studies, continuous-infusion models, or high-throughput in vitro binding assays that require a consistent single-lot peptide supply.
To ensure structural integrity and long-term chemical stability, the peptide is sealed under inert nitrogen atmosphere within USP Type I borosilicate glass vials, capped with fluoropolymer-coated chlorobutyl stoppers. PX1 Research provides high-purity metabolic research compounds, including Retatrutide (GLP-3R), available within our full catalog of research peptides. Researchers requiring specific 15mg unit sizes utilize these standardized vials to maintain low batch-to-batch variability across extended experimental timelines.
Triple Agonist Mechanism of Action in Preclinical Models
Retatrutide operates as a unimolecular multi-agonist, engaging GIPR, GLP-1R, and GCGR to initiate downstream intracellular signaling cascades via heterotrimeric G-protein activation. In vitro receptor transactivation assays demonstrate that retatrutide exhibits potent activity across all three human and rodent receptor subtypes, stimulating cyclic adenosine monophosphate (cAMP) accumulation in a concentration-dependent manner.
In preclinical animal models, researchers utilize retatrutide to evaluate the synergistic metabolic impact of simultaneous GIP, GLP-1, and glucagon receptor activation. In vitro assays demonstrate that while GLP-1 and GIP signaling pathways enhance glucose-dependent insulin secretion and suppress appetite signaling in central neuronal circuits, glucagon receptor engagement modulates hepatic lipid oxidation and energy expenditure pathways. Investigating these combined pathways allows laboratories to explore complex receptor crosstalk without compounding variables from multi-drug co-administration.
Comparative Analysis: Retatrutide vs. Dual and Single Agonists
When designing comparative metabolic experiments, researchers frequently benchmark retatrutide against established single- and dual-acting incretin mimetics. Single-target agonists, such as semaglutide, target the GLP-1 receptor exclusively, providing a baseline for metabolic rate alterations, glycemic control assays, and appetite pathway mapping in rodent models.
Dual-target compounds, such as tirzepatide, integrate GIP and GLP-1 receptor agonism, producing enhanced insulinotropic response and metabolic modulation compared to selective GLP-1 stimulation. Retatrutide extends this spectrum by incorporating glucagon receptor binding. Furthermore, researchers investigating complementary metabolic pathways often compare or co-evaluate these incretin mimetics alongside amylin receptor agonists like cagrilintide to map non-incretin satiety signaling in central nervous system tissue preparations.
Reconstitution Math and Diluent Volume Calculations for 15mg Vials
Accurate reconstitution of a 15mg retatrutide vial is critical for achieving target working concentrations in laboratory protocols. The concentration ($C$) of the reconstituted solution is calculated using the mass of the peptide ($m = 15\text{ mg}$) divided by the volume of added diluent ($V$): $C = m / V$. Depending on the requirements of the microfluidic system or animal dosing apparatus, common reconstitutions utilize 1.0 mL, 2.0 mL, or 3.0 mL of sterile bacteriostatic water (0.9% benzyl alcohol) or laboratory-grade sterile saline.
Adding 1.0 mL of diluent to a 15mg vial yields a high-density working concentration of $15.0\text{ mg/mL}$ ($15.0\mu\text{g/}\mu\text{L}$). Adding 2.0 mL of diluent results in a concentration of $7.5\text{ mg/mL}$ ($7.5\mu\text{g/}\mu\text{L}$). Reconstituting with 3.0 mL of diluent yields $5.0\text{ mg/mL}$ ($5.0\mu\text{g/}\mu\text{L}$). To calculate custom volumetric additions or micro-dose dilutions accurately, researchers should consult our online reconstitution calculator prior to fluid handling.
Aliquot Planning and Laboratory Handling Protocols
To preserve the secondary and tertiary structural integrity of retatrutide during reconstitution, diluent must be introduced gently down the inner glass wall of the vial using a low-binding precision syringe or micropipette. The vial should be slowly swirled or rotated until the lyophilized cake fully dissolves into a clear, colorless solution. Avoid vigorous shaking, vortexing, or ultrasonic agitation, as mechanical shear stress can induce peptide denaturation, aggregation, or precipitation.
Once dissolved, if the entire 15mg volume will not be consumed in a single experimental run, the solution should immediately be divided into working aliquots using sterile, polypropylene microcentrifuge tubes (preferably low protein-binding). Sub-aliquoting minimizes freeze-thaw cycles, which degrade peptide potency over time through physical disruption of hydrogen bonding networks.
Storage Parameters and Lyophilized vs. Reconstituted Stability
Lyophilized retatrutide 15mg vials exhibit maximal chemical stability when stored in a desiccated freezer environment at $-20^\circ\text{C}$ or lower, protected from light exposure. Under these conditions, the unconstituted peptide maintains specified purity levels for extended durations by suppressing hydrolytic and oxidative degradation pathways.
Following reconstitution with bacteriostatic water, the solution may be stored under refrigerated conditions ($2^\circ\text{C}$ to $8^\circ\text{C}$) for up to 28 days, provided aseptic technique is strictly maintained. For long-term preservation of reconstituted solutions beyond 30 days, working aliquots must be frozen at $-80^\circ\text{C}$. Frozen liquid aliquots should be thawed slowly on ice immediately before experiment initiation and must never be refrozen once thawed.
Analytical Quality Control: HPLC, Mass Spectrometry, and Endotoxin Testing
PX1 Research mandates strict analytical testing on every lot of retatrutide to verify sequence fidelity and quantitative purity. Analytical verification is conducted via high-performance liquid chromatography (HPLC) paired with electrospray ionization mass spectrometry (ESI-MS) in ISO 17025 accredited laboratories. Every batch must demonstrate an HPLC chromatographic purity of $\ge 99.0\%$, ensuring the absence of truncated sequences or synthesis side-products.
Furthermore, because bacterial endotoxins interfere with cell culture viability and induce non-specific inflammatory signaling in animal models, all batches undergo Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain strictly below $< 0.01\text{ EU/mg}$. Researchers can download and inspect the complete analytical breakdown for their specific vial lot via our dedicated lot-matched COA portal.
Selecting the Optimal Vial Size: 15mg vs. Alternative Formats
Choosing between a 15mg vial and alternative fill sizes (such as 5mg or 10mg) depends primarily on experimental scale, subject group size, and planned dosage duration. A 15mg vial provides operational efficiency for longitudinal rodent protocols requiring consistent daily micro-volume administrations across multiple subject groups from a single master lot.
Conversely, for short-term pilot studies, single-plate assay screening, or preliminary bioactivity validation, smaller vial masses are often advantageous to prevent reagent waste and limit extended storage of reconstituted liquid solutions. Researchers evaluating study designs and reagent requirements can consult our preclinical research library for methodology references and protocol guidelines.
PX1 Research Quality Standards and Institutional Procurement
PX1 Research synthesizes and packages all research peptides in US-based, GMP-compliant facilities. Our rigorous quality control framework guarantees that every vial meets verified standards for identity, purity, peptide content, and endotoxin compliance before release to academic and commercial research entities.
To support high-throughput laboratories and institutional procurement programs, PX1 provides rapid fulfillment with same-day shipping on orders placed Monday through Friday from our California and Arizona distribution hubs. Laboratories requiring bulk quantities, custom packaging specs, or standing supply contracts can request dedicated support through our wholesale institutional accounts portal.
Frequently Asked Questions
What is the certified purity level of PX1 retatrutide 15mg vials?
PX1 retatrutide 15mg research vials are verified via RP-HPLC to meet or exceed 99.0% chromatographic purity, accompanied by mass spectrometry identity confirmation.
How do I calculate the concentration of retatrutide after adding 2mL of diluent to a 15mg vial?
Adding 2.0 mL of diluent to a 15mg vial yields a final concentration of 7.5 mg/mL (7.5 micrograms per microliter).
Is retatrutide 15mg intended or approved for human clinical use?
No. Retatrutide 15mg is supplied strictly as a research-grade chemical for in vitro assays and laboratory animal research. It is strictly prohibited for human or veterinary medical use.
How long can reconstituted retatrutide remain stable under refrigeration?
When reconstituted with bacteriostatic water containing 0.9% benzyl alcohol using aseptic technique, liquid retatrutide maintains stability at 2°C to 8°C for up to 28 days.
What are the endotoxin limits for retatrutide research vials?
PX1 retatrutide undergoes LAL endotoxin testing to ensure levels remain below 0.01 EU/mg, preventing endotoxin-induced interference in cell cultures or animal bioassays.
How does retatrutide differ mechanistically from dual GIP/GLP-1 agonists?
Unlike dual agonists that activate only GIP and GLP-1 receptors, retatrutide is a triple agonist that engages GIP, GLP-1, and glucagon receptors simultaneously.
How do I access the Certificate of Analysis (COA) for my specific vial lot?
Lot-matched COAs containing HPLC chromatograms and Mass Spec data can be downloaded directly using the lot number printed on your vial label via our COA portal.
What volume of diluent is recommended for long-term multi-dose sampling from a 15mg vial?
Reconstituting with 2.0 mL or 3.0 mL of diluent yields concentrations of 7.5 mg/mL and 5.0 mg/mL respectively, which facilitate accurate volumetric sampling with standard laboratory micropipettes.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.